Cardiac device infections represent one of the most serious complications in modern cardiology, with infection rates potentially reaching devastating consequences for patients with pacemakers and defibrillators. Despite established protocols, gaps remain in preventing these life-threatening complications, prompting specialists to seek evidence-based strategies that extend beyond current official recommendations.
A modified Delphi consensus process brought together cardiologists and infectious disease experts to establish best practices where guidelines remain silent. The panel achieved strong agreement on several key interventions, including mandatory double-gloving during procedures to reduce contamination risk and systematic use of validated risk assessment models like PADIT and BLISTER to stratify patient vulnerability. The consensus also endorsed emerging technologies such as taurolidine-containing antimicrobial agents and specialized incision drapes, though these rely primarily on observational rather than randomized trial data.
This expert convergence addresses a critical knowledge gap in cardiac device management. While established interventions like antibiotic-eluting envelopes and leadless pacemakers have robust trial support, many practical infection prevention strategies lack definitive evidence yet show clinical promise. The consensus represents a pragmatic bridge between research limitations and clinical necessity, offering practitioners guidance where formal guidelines remain incomplete. For patients facing cardiac device implantation, these recommendations could translate into meaningfully reduced infection risk through standardized application of multiple complementary strategies. The work highlights how expert consensus can advance patient care even when awaiting definitive trial evidence for emerging protective approaches.